Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suzanne Greiner

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Nature Medicine|October 28, 2008
Engineering microRNA responsiveness to decrease virus pathogenicityElizabeth J Kelly, Elizabeth M Hadac, Suzanne Greiner, et al.
Blood|January 21, 2006
Synergistic activity of the proteasome inhibitor PS-341 with non-myeloablative 153-Sm-EDTMP skeletally targeted radiotherapy in an orthotopic model of multiple myelomaApollina Goel, Angela Dispenzieri, Susan M Geyer, et al.
Neoplasia (New York, N.Y.)|December 21, 2010
Dexamethasone-induced oxidative stress enhances myeloma cell radiosensitization while sparing normal bone marrow hematopoiesisSoumen Bera, Suzanne Greiner, Amit Choudhury, et al.
Nature Biotechnology|February 3, 2005
Rescue and propagation of fully retargeted oncolytic measles virusesTakafumi Nakamura, Kah-Whye Peng, Mary Harvey, et al.
Hepatology (Baltimore, Md.)|November 30, 2006
Engineered measles virus as a novel oncolytic viral therapy system for hepatocellular carcinomaBoris Blechacz, Patrick L Splinter, Suzanne Greiner, et al.
Blood|May 23, 2007
Radioiodide imaging and radiovirotherapy of multiple myeloma using VSV(Delta51)-NIS, an attenuated vesicular stomatitis virus encoding the sodium iodide symporter geneApollina Goel, Stephanie K Carlson, Kelly L Classic, et al.
Human Gene Therapy|October 28, 2003
Biodistribution of oncolytic measles virus after intraperitoneal administration into Ifnar-CD46Ge transgenic miceKah-Whye Peng, Marie Frenzke, Rae Myers, et al.
Cancer Gene Therapy|March 5, 2005
Oncolytic activities of approved mumps and measles vaccines for therapy of ovarian cancerRae Myers, Suzanne Greiner, Mary Harvey, et al.
Cancer Research|May 17, 2003
Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiformeLoi K Phuong, Cory Allen, Kah-Whye Peng, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Nature Medicine|October 28, 2008
Engineering microRNA responsiveness to decrease virus pathogenicityElizabeth J Kelly, Elizabeth M Hadac, Suzanne Greiner, et al.
Blood|January 21, 2006
Synergistic activity of the proteasome inhibitor PS-341 with non-myeloablative 153-Sm-EDTMP skeletally targeted radiotherapy in an orthotopic model of multiple myelomaApollina Goel, Angela Dispenzieri, Susan M Geyer, et al.
Neoplasia (New York, N.Y.)|December 21, 2010
Dexamethasone-induced oxidative stress enhances myeloma cell radiosensitization while sparing normal bone marrow hematopoiesisSoumen Bera, Suzanne Greiner, Amit Choudhury, et al.
Nature Biotechnology|February 3, 2005
Rescue and propagation of fully retargeted oncolytic measles virusesTakafumi Nakamura, Kah-Whye Peng, Mary Harvey, et al.
Hepatology (Baltimore, Md.)|November 30, 2006
Engineered measles virus as a novel oncolytic viral therapy system for hepatocellular carcinomaBoris Blechacz, Patrick L Splinter, Suzanne Greiner, et al.
Blood|May 23, 2007
Radioiodide imaging and radiovirotherapy of multiple myeloma using VSV(Delta51)-NIS, an attenuated vesicular stomatitis virus encoding the sodium iodide symporter geneApollina Goel, Stephanie K Carlson, Kelly L Classic, et al.
Human Gene Therapy|October 28, 2003
Biodistribution of oncolytic measles virus after intraperitoneal administration into Ifnar-CD46Ge transgenic miceKah-Whye Peng, Marie Frenzke, Rae Myers, et al.
Cancer Gene Therapy|March 5, 2005
Oncolytic activities of approved mumps and measles vaccines for therapy of ovarian cancerRae Myers, Suzanne Greiner, Mary Harvey, et al.
Cancer Research|May 17, 2003
Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiformeLoi K Phuong, Cory Allen, Kah-Whye Peng, et al.
Pageof 1